CancerCare's 2016 Patient Access and Engagement Report underscores barriers for patient access to care, as well as communication gaps with care providers, both of which have a significant impact on patient outcomes.
CancerCare, an organization that provides information and support services to cancer patients, has commissioned a report that presents the physical, financial, practical, and informational needs of more than 3000 cancer patients. The 2016 Patient Access and Engagement Report has tried to reflect barriers for patient access to care, as well as communication gaps with care providers, both of which have a significant impact on patient outcomes.
The advisory board that helped develop the report included healthcare providers and leaders within CancerCare. Patients who participated in the survey represented diverse ethnicity, income, education, geography, age, insurance, cancer type, and treatment stage. The following are some of the findings of the study:
Understanding Diagnosis
Treatment Planning
Communication With Care Team
Financial and Insurance Issues
Symptoms, Side Effects, and Quality of Life
Survivorship
“Cancer takes its toll in many ways, some of which last for years and cause debilitating distress for patients and families,” Patricia J. Goldsmith, CEO of CancerCare, said in a statement. “This report, reflecting the input of thousands of patients, sheds light on the important issues affecting patients’ lives during and beyond a cancer diagnosis.”
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More